Posted on February 6th, 2017 by UNM CC
In 2017, the Pancreatic Cancer Action Network will invest $12.8 million in innovative research, a 33 percent increase over last year. This investment includes both our competitive, peer-reviewed Research Grants Program and our internal research initiatives. We are now accepting applications for our 2017 funding opportunities. Please see full details in the RFAs.
Download and share flier for our Precision Medicine and Early Detection Targeted Grants.
Precision Medicine Targeted Grant
Amount: Up to $1,000,000 | Duration: Up to two years
Funding available for projects that can be incorporated directly into the Pancreatic Cancer Action Network’s Precision Promise initiative at the end of the funding period.
DEADLINE: February 15, 2017, Noon EST
Early Detection Targeted Grant
Amount: Up to $1,000,000 in milestone-driven units of $250,000 | Duration: Up to four years
Supports studies to utilize a cohort of new onset diabetics with high risk of sporadic pancreatic cancer; projects will focus on blood biomarkers or imaging strategies.
DEADLINE: February 22, 2017, Noon EST
KRAS Travel Scholarship (in partnership with the NCI Frederick National Laboratory for Cancer Research)
Provides travel support to a researcher at any career stage, during or after the postdoctoral level, to visit FNLCR to pursue KRAS research that is directly relevant to pancreatic cancer with aims aligned with the RAS Initiative
Amount: Depending on need
Application deadline: Rolling
You must be logged-in to the site to post a comment.